PIUR IMAGING, today announced that Kevin Goodwin has joined the company as a Strategic Advisor. With more than 35 years of experience building and scaling ultrasound and AI-enabled ultrasound technologies, Goodwin brings a track record spanning category creation, global commercialization, and landmark exit experience. His appointment comes as PIUR advances its U.S. commercial rollout following FDA clearance and prepares for its next major growth financing round.
PIUR and Kevin Goodwin: A Strategic Fit for the Next Era of Ultrasound
PIUR IMAGING has developed a vendor-agnostic, FDA-cleared add-on technology designed to transform standard 2D ultrasound systems into tomographic 3D imaging platforms. Paired with AI-powered image analysis, PIUR’s technology helps address operator dependency by delivering reproducible, organ-level volumetric data to support faster, more confident clinical decisions.
Kevin Goodwin has spent his career developing technologies that make ultrasound more accessible and clinically powerful. As founder and CEO of Sonosite following its 1998 spin-off from ATL Ultrasound, he played a defining role in building the POCUS market, growing Sonosite from an emerging company into a global ultrasound leader before its acquisition by FUJIFILM in 2012. He later co-founded EchoNous to bring artificial intelligence and deep learning into POCUS, building the Kosmos platform and further expanding the role of intelligent, portable imaging in clinical care.
“Having Kevin Goodwin in our corner is a genuine game-changer. He didn’t just witness the transformation of diagnostic ultrasound, he led it, twice. Kevin understands exactly what it takes to build a category-defining medical technology company and get it to scale. His conviction in PIUR’s technology and our U.S. market opportunity validates everything we have been building toward. With Kevin’s guidance, we are ready to move from breakthrough innovation to breakout commercial success.” Frederik Bender, CEO & Managing Director, PIUR IMAGING
The strategic fit between Goodwin’s experience and PIUR’s opportunity is striking. Just as Sonosite helped democratize bedside ultrasound by making it portable and accessible, PIUR is working to democratize 3D diagnostic imaging by bringing advanced tomographic ultrasound to existing ultrasound infrastructure. And just as EchoNous applied AI to make POCUS more reliable, PIUR’s platform uses AI to help reduce the subjectivity of traditional 2D scans.
Why Kevin Goodwin, Why Now
PIUR IMAGING is at an inflection point. The company has achieved FDA clearance and CE marking, established a U.S. subsidiary, and secured its first commercial partnerships, including integration into select GE HealthCare LOGIQ scanners through its PIUR tUS inside product. With healthcare systems facing a well-documented shortage of specialist imaging expertise, and growing institutional demand for AI-enabled, reproducible imaging workflows, PIUR sees a substantial commercial opportunity ahead.
With regulatory approvals secured, commercial partnerships underway, and demand growing, PIUR is entering its next phase of expansion. Kevin Goodwin’s experience scaling healthcare businesses will support the company’s global ambitions. His role as Strategic Advisor will focus on three high-impact priorities:
U.S. Commercial Strategy: Drawing on his deep experience working with hospital systems, radiology departments, and healthcare distributors, Goodwin will help PIUR sharpen its U.S. go-to-market approach and accelerate customer acquisition.
Investor Positioning & Fundraising: Having raised and deployed over $130M in private capital and led a public company through a landmark exit, Goodwin will help bring PIUR’s investment story to strategically relevant audiences.
Scaling Operations & Partnerships: Goodwin’s experience scaling Sonosite across Asia-Pacific, Latin America, Europe, and North America will inform PIUR’s international expansion strategy and OEM partnership development.
“I have spent my entire career trying to make ultrasound more useful, more accessible, and more reliable. When I first encountered PIUR’s technology, I immediately recognized what the team has built: a genuinely transformative solution that makes 3D tomographic imaging available everywhere, with any scanner. This is the next great leap for the field, and a compelling commercial and investment opportunity. I’m proud to help PIUR bring it to scale.” Kevin Goodwin, Strategic Advisor, PIUR IMAGING | Founder & Former CEO, Sonosite
About PIUR IMAGING
PIUR IMAGING is an ISO 13485-certified and FDA-cleared MedTech company with offices in Austria, Germany, and the United States. The company develops AI-powered 3D ultrasound solutions designed to enhance everyday clinical workflows and enable scalable, reproducible, and efficient diagnostic imaging.
About Kevin Goodwin
Kevin Goodwin is one of the most accomplished executives in the global ultrasound industry, with more than 35 years of leadership experience across ultrasound, medical devices and AI-driven health technology. He founded Sonosite in 1998 as a spin-off from ATL Ultrasound, building it into the world’s leading point-of-care ultrasound company with more than $300M in annual revenue before its acquisition by FUJIFILM in 2012 for nearly $1 billion. He subsequently co-founded EchoNous, where he helped lead the development of the AI-powered Kosmos POCUS platform, which secured FDA 510(k) clearance and attracted more than $130M from institutional investors including KKR and Kennedy Lewis Investment Management. Goodwin is recognized as a pioneer in the commercialization of AI and machine learning applied to diagnostic ultrasound imaging.
